Published: 12/29/2020 12:24 GMT Eyenovia Inc (EYEN) - Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis With Mydcombi Targeting 80 Million Patient Encounters in the U.S. Annually.
Eyenovia Inc - If Approved, Mydcombi Could Be Available Late Next Year Or Early 2022.
